Z-1217-2017 Class III Terminated

Recalled by Siemens Healthcare Diagnostics, Inc. — Newark, DE

FDA device recall Z-1217-2017 was initiated by Siemens Healthcare Diagnostics, Inc. on May 5, 2016 and is designated Class III. Reason for recall: Complaints of positive shift of patient and QC results when the ALTI assay is calibrated with the Dimension Enzyme II calibrator. Internal investigation has confirmed that patient samples and QC… The recall status is terminated (terminated Feb 2, 2018). Affected quantity: 24,940.00.

Recall details

Product Type
Devices
Report Date
Feb 22, 2017
Initiation Date
May 5, 2016
Termination Date
Feb 2, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24,940.00

Product description

The Enzyme II Calibrator is an in vitro diagnostic product for the Alanine Aminotransferase (ALTI) on the Dimension¿ clinical chemistry system. For prescription use only.

Reason for recall

Complaints of positive shift of patient and QC results when the ALTI assay is calibrated with the Dimension Enzyme II calibrator. Internal investigation has confirmed that patient samples and QC material demonstrate a shift of up to 10% in comparison to results obtained using earlier calibrator lots.

Distribution pattern

Distributed throughout the United States

Code information

Product Lot: 4MD047, 5CD052, 5FD017, 5GD050, 5HD010, 5JD069, 5LD051, 6AD054

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1217-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1217-2017. Report a data issue: hello@regdatalab.com.